CytoDyn Inc. CYDY
OTC PK
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.94M | -9.86M | -4.69M | -22.61M | -5.54M |
| Total Depreciation and Amortization | 19.00K | 4.00K | 4.00K | 5.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.72M | 823.00K | 2.07M | 483.00K | 179.00K |
| Change in Net Operating Assets | -4.53M | 4.10M | -2.91M | 17.77M | 2.91M |
| Cash from Operations | -7.73M | -4.93M | -5.52M | -4.35M | -2.45M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -142.00K |
| Issuance of Common Stock | 12.23M | 1.13M | 15.32M | 0.00 | 21.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 874.00K | -- | -- |
| Cash from Financing | 12.23M | 1.13M | 16.19M | 0.00 | -121.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.51M | -3.80M | 10.67M | -4.35M | -2.57M |